Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Going Viral: How to Find & Engage Your Audience to Become a Podcast Celebrity

Jason Liebowitz, MD, FACR  |  January 9, 2024

Dr. Brown illustrated this point by considering a medication that most rheumatologists have heard of—allopurinol—and asking: How was it discovered that allopurinol should not be combined with azathioprine? He explained that in the mid-20th Century, 6-mercapatopurine (6-MP) was found to be effective for treating patients with acute lymphoblastic leukemia. To enhance the action of 6-MP, researchers found that 6-MP could be combined with allopurinol. Although this finding was helpful in the world of oncology, this drug combination can be dangerous when used to treat diseases other than cancer.1

Dr. Brown explained that rheumatologists are warned not to combine allopurinol and azathioprine because azathioprine is the prodrug that breaks down into 6-MP. Combining the two may result in high levels of 6-MP, which can cause blood dyscrasias in some patients.2 By demonstrating the power of historical context and storytelling, Dr. Brown showed the audience how podcasters can both teach and entertain at the same time.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Audience Engagement

The next speaker, Cheryl Crow, MOT, OTR/L, an occupational therapist from Bellevue, Wash., is the founder and the host of the Arthritis Life podcast. She is a health professional living with rheumatoid arthritis and has drawn from this aspect of her life to create a podcast series with more than 130,000 downloads.

Mrs. Crow spoke about how to amplify podcast content. Her approach relies on three steps:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Know your audience;
  • Create compelling content; and
  • Connect and follow through.

In terms of knowing your audience, podcasters should ask themselves: Where does my audience hang out online (i.e., Instagram, TikTok, Facebook)? What problems does my audience have that they would want to see addressed?

Mrs. Crow said her most popular podcast episode to date is titled, What’s It Like to Be on Methotrexate? The episode’s popularity surprised Mrs. Crow because she thought that its title wasn’t particularly creative and that the topic would not lure in listeners. However, she learned that a simple title goes a long way if it aligns with the phrases (i.e., search terms) people type into Google. She also discovered that a topic that might seems banal to her—she has been on methotrexate for 20 years—may be highly relevant to people starting this medication. 

Producing compelling content can be done by creating static images, audiograms, short video excerpts and promo videos, long form videos and hosting live chats. Each of these content formats helps to attract and engage an audience so that they will explore related content from the same producer.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceCareerMeeting Reports Tagged with:ACR Convergence 2023ACR on Airpodcast

Related Articles
    Diagnosis Can Be Elusive for Fever of Unknown Origin

    Diagnosis Can Be Elusive for Fever of Unknown Origin

    March 15, 2016

    Settling into room 501 at Maine Medical Center, Mrs. N was on her way to the bathroom when she felt it coming on. One moment she was okay; the next, her chest felt damp and cold, even as her face flushed and her temperature spiked. Her forehead glistened beads of warm sweat. She felt the…

    Bridge the Gap Between Goal and Attainment

    May 1, 2010

    Use motivational interviewing to facilitate behavior change for your clients

    Monkey Business Images/shutterstock.com

    Assessing Autoimmune Disease Symptoms in Silicone Breast Implant Recipients

    December 15, 2016

    My nurse, Joanne, took me aside before I began my next consult. “Room No. 5, breast implant patient. Her lawyer organized the records.” She handed me a hefty three-ring notebook organized by color-coded tabs. “Her attorney called just now,” Joanne raised an eyebrow, “and told me to tell you that, to save time, he highlighted…

    ACR on Air: New Rheumatology Podcast Introduced

    September 2, 2019

    A new podcast from the ACR provides in-depth discussions about newly published science, regulatory updates, advocacy and volunteer opportunities for the rheumatology community…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences